Compremium

Focus: Compremium is a Swiss diagnostics company specializing in non-invasive measurement tools for vascular and tissue health conditions. The company operates at early stages with a focused pipeline addressing compartment syndromes, liver cirrhosis, and intracranial pressure monitoring.

Vascular Health

Profile data last refreshed 18h ago · AI intelligence enriched 2w ago

Total Funding

$35M

Open Jobs

About Compremium

AI assessmentNot Hiring

No open roles listed right now. Follow Compremium to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Measurement of compartment compressibility using the CPMX1 device

Compartment Syndromes

N/A

Clinical Trials (1)

NCT06030635ACS Monitoring Charité Berlin

N/A

Help build intelligence for Compremium

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity in a Swiss-based diagnostic device company with novel compartment compressibility measurement technology
Diverse pipeline spanning multiple high-value indications (compartment syndromes, liver cirrhosis, cardiac ICU, intracranial pressure) suggests broad clinical validation pathway
Switzerland headquarters positions you in a tier-1 biotech regulatory and investment hub with strong IP protection culture

Watch Out For

Zero active job openings signals company is not in active growth or hiring phase, limiting near-term career mobility
Missing foundational data—no employee count, founding date, funding amount, or revenue—indicates limited public visibility and transparency
All pipeline programs lack standard development phase designation (marked 'N/A'), suggesting early preclinical or exploratory stage with uncertain timelines to clinical trials

Generated by Claude from Compremium's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Measurement of compartment compressibility

Compartment Syndromes

N/A

Clinical Trials (1)

NCT05483946SWISS_CLEARANCE - Compartment Compressibility Monitoring Using CPM#1

N/A

CPMX3

Intracranial Pressure

N/A

Clinical Trials (2)

NCT07222826Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein

N/A

NCT07550361Validation of Non-Invasive Intracranial Pressure Estimation Using CPMX3 in the Periorbital Vein: A Feasibility Study in Pediatric Patients

N/A

CPMX2

Cardiac Intensive Care

N/A

Clinical Trials (1)

NCT07226479Non-invasive Venous Pressure Estimation

N/A

CPMX2

Central Venous Pressure

N/A

Clinical Trials (1)

NCT06885073Non-invasive Central Venous Pressure Estimation in Pediatric Patients

N/A

Measurement of compartment compressibility

Compartment Syndromes

N/A

Clinical Trials (1)

NCT05367921SWISS_EVIDENCE - Compartment Compressibility Monitoring Using CPM#1

N/A

CPMX2

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT06544161EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin Substitution

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 8 clinical trials

Top TAs: Gastroenterology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Gastroenterology

1 pipeline

Marketed

Pipeline